Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial
Name:
Clinical outcomes of.pdf
Size:
702.5Kb
Format:
PDF
Description:
Found with Open Access Button
Authors
Hamadani, MSpira, AI
Zhou, X
Liao, L
Chen, L
Radford, John
Ai, WZ
Solh, MM
Ardeshna, KM
Hess, BT
Caimi, PF
Stathis, A
Carlo Stella, C
Alderuccio, JP
Kahl, BS
Wang, Y
Qin, YG
Xu, ZC
Zinzani, PL
Affiliation
University of Manchester and the Christie NHS Foundation Trust, Manchester, United Kingdom.Issue Date
2023
Metadata
Show full item recordCitation
Hamadani M, Spira AI, Zhou X, Liao L, Chen L, Radford J, et al. Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial. Blood advances. 2023 Oct 23. PubMed PMID: 37871303. Epub 2023/10/23. eng.Journal
Blood AdvancesDOI
10.1182/bloodadvances.2023010636PubMed ID
37871303Additional Links
https://dx.doi.org/10.1182/bloodadvances.2023010636Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/bloodadvances.2023010636
Scopus Count
Collections
Related articles
- Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma.
- Authors: Xu B
- Issue date: 2022 May
- Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.
- Authors: Caimi PF, Ai W, Alderuccio JP, Ardeshna KM, Hamadani M, Hess B, Kahl BS, Radford J, Solh M, Stathis A, Zinzani PL, Havenith K, Feingold J, He S, Qin Y, Ungar D, Zhang X, Carlo-Stella C
- Issue date: 2021 Jun
- Evaluating efficacy and safety of loncastuximab tesirine injection for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.
- Authors: Ahmed N, Hamadani M
- Issue date: 2021 Dec
- Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study.
- Authors: Alderuccio JP, Ai WZ, Radford J, Solh M, Ardeshna KM, Lunning MA, Hess BT, Zinzani PL, Stathis A, Carlo-Stella C, Hamadani M, Kahl BS, Ungar D, Kilavuz T, Yu E, Qin Y, Caimi PF
- Issue date: 2022 Aug 23
- Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Authors: Spira A, Zhou X, Chen L, Gnanasakthy A, Wang L, Ungar D, Curiel R, Liao L, Radford J, Kahl B
- Issue date: 2022 Mar